Products Categories

Cetyl Salicylic Acid; Aspir...

Agilent Analytical Laborato...

Lefamulin Acetate CAS No. 1...

Gatifloxacin Mesylate CAS N...

Gatifloxacin CAS No. 112811...

Flumequine Sodium CAS No. 4...

Flumequine CAS No. 42835-25...

Florfenicol CAS No. 73231-3...

Finasteride CAS No. 98319-2...

Enrofloxacin HCL CAS No. 11...

0102030405

CAS NO.124655-09-0 Intermediates of Rosuvastatin Calcium (2).png

INDACATEROL MALEATE Intermediates CAS No 530084-79-8 Pharmaceutical Intermediates

Product Name	INDACATEROL MALEATE Intermediates
Other Name	8-BENZYLOXY-5-((R)-2-BROMO-1-HYDROXYETHYL)-1H-QUINOLINONE
CAS No.	530084-79-8
EINECS	/
Formula	C18H16BrNO3
Molecular Weight	374.23
Appearance	Light Beige Solid
Purity	≥98%
Type	Pharmaceutical Intermediates

Innovative Drug Intermediate: 8-Benzyloxy-5-((R)-2-bromo-1-hydroxyethyl)-1H-quinolinone is a novel compound with great potential in drug development, especially in the treatment of various diseases.

High Purity & Quality: Produced in our state-of-the-art facility to ensure the highest pharmaceutical standards.

Integrated Production and Trading: As a production and trading integrated factory, we provide competitive prices and reliable supply chain solutions.

Regulatory Compliance: Our products meet all necessary regulatory requirements to ensure safety and efficacy in pharmaceutical applications.

Research-Backed Efficacy: Backed by extensive research, this compound shows great potential in a variety of therapeutic applications.

product details

Product details

Product detail

8-Benzyloxy-5-((R)-2-bromo-1-hydroxyethyl)-1H-quinolinone is a special compound that plays a vital role in the pharmaceutical industry. Its unique structure makes it an important intermediate in the synthesis of various pharmaceutical agents. This compound is particularly well known for its application in the development of drugs targeting a range of medical conditions, including cancer, infectious diseases, and neurodegenerative diseases. The presence of bromine and hydroxyl groups in its structure enhances its reactivity and versatility, making it a valuable building block in medicinal chemistry.

product detail

CAS No.	40856-44-8
EINECS	609-874-3
Formula	C9H11NO2
Molecular Weight	165.19
Appearance	White to Off-White solid
Purity	≥98%
Type	Pharmaceutical Intermediates

Physical and Chemical Properties

8-Benzyloxy-5-((R)-2-bromo-1-hydroxyethyl)-1H-quinolinone possesses unique physical and chemical properties that contribute to its effectiveness as a pharmaceutical agent.

- Molecular formula: C18H16BrNO3

- Molecular weight: 374.23 g/mol

- Appearance:Light Beige Solid

- Solubility: Soluble in dimethyl sulfoxide (DMSO) and methanol; slightly soluble in water

- Melting point: approx. 150-155 °C

- Stability: Stable under normal storage conditions for the recommended shelf life, ensuring long-term efficacy.

These properties not only enhance the performance of the compounds but also facilitate their formulation into various pharmaceutical products including tablets, capsules, and injections.

Advantages

The advantages of 8-Benzyloxy-5-((R)-2-bromo-1-hydroxyethyl)-1H-quinolinone are not limited to its chemical composition. Here are some of the key advantages that make it a top choice in the pharmaceutical industry:

1. Targeted Therapeutic Applications: The unique structure of this compound allows for targeted interactions with specific biological pathways, thereby enhancing its effectiveness in treating various diseases, particularly in oncology and neurology.

2. Enhanced reactivity: The presence of bromine and hydroxyl groups increases the reactivity of the compound, making it suitable for a wide range of chemical reactions and medicinal chemistry applications.

3. Improved bioavailability: The chemical properties of 8-benzyloxy-5-((R)-2-bromo-1-hydroxyethyl)-1H-quinolinone help improve absorption and bioavailability in the body, resulting in better therapeutic effects when used in pharmaceutical formulations.

4. Research Driven Development: After extensive research, this compound has shown good promise in various therapeutic areas, making it a valuable addition to any drug portfolio.

5. Full Support: Our integrated factory model ensures that we provide not only products but also full support, including technical assistance and regulatory guidance.

Committed to Quality and Compliance

As a factory integrating production and trading, we are proud of our commitment to quality and compliance. Our production process follows Good Manufacturing Practice (GMP), ensuring that each batch of 8-Benzyloxy-5-((R)-2-bromo-1-hydroxyethyl)-1H-quinolinone meets strict quality standards. From raw materials to finished products, we conduct rigorous testing at every stage of production to ensure safety and effectiveness.

Our factory is equipped with advanced technology and staffed by a team of experienced professionals dedicated to maintaining the highest level of quality control. We understand the critical nature of pharmaceutical products and are committed to providing the best products to our customers.

In summary

In summary, 8-benzyloxy-5-((R)-2-bromo-1-hydroxyethyl)-1H-quinolinone represents a significant advancement in drug development. With its unique physical and chemical properties, proven efficacy, and our commitment to quality, it has become the first choice of the pharmaceutical industry. As a factory integrating production and trading, we are capable of meeting the growing demand for this essential compound, ensuring that healthcare providers and patients have access to the best treatment options. Choose 8-benzyloxy-5-((R)-2-bromo-1-hydroxyethyl)-1H-quinolinone for reliable and effective solutions for pharmaceutical applications.